| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| Adesto Technologies (IOTS) | Needham & Company/ Oppenheimer & Co. | $50.00 | n.a. | |||
| Andina Acquisition Corp. II (TBA) (u) | EarlyBirdCapital, Inc. | 4.00 | $10.00 | $10.00 | $40.00 | n.a. |
| Dimension Therapeutics (DMTX) | Goldman Sachs/ Citigroup/ Wells Fargo Securities | $115.00 | n.a. | |||
| n.a. (not available) | $205.00 | |||||
| TBA (to be announced) | ||||||
| u (unit offering) | ||||||
| Postponed | ||||||
| None | ||||||
| Withdrawn | ||||||
| SRA Companies (TBA) | BofA Merrill Lynch/ Citigroup | $100.00 | n.a. | |||
| New Terms | ||||||
| Aeglea BioTherapeutics (AGLE) | UBS Investment Bank/ BMO Capital Markets | $86.25 | n.a. | |||
| Boulevard Acquisition Corp. II (BLVDU) (u) | Citigroup | 35.00 | $10.00 | $10.00 | $350.00 | 1-Star |
| Capitol Acquisition Corp. III (CLACU) (u) | Citigroup | 35.00 | $10.00 | $10.00 | $350.00 | n.a. |
| Fuling Global (FORK) | Burnham Securities | 5.00 | $5.00 | $7.00 | $30.00 | N/C |
| Mirna Therapeutics (MIRN) | Citigroup/ Leerink Partners | 4.65 | $13.00 | $15.00 | $65.10 | n.a. |
| Multi Packaging Solutions International (MPSX) | BofA Merrill Lynch/ Barclays/ Citigroup | $100.00 | n.a. | |||
| Nabriva Therapeutics AG (NBRV) | Leerink Partners/ RBC Capital Markets | 9.00 | $10.50 | $10.50 | $94.50 | 2-Stars |
| REGENXBIO Inc. (RGNX) | Morgan Stanley/ BofA Merrill Lynch/ Piper Jaffray | 5.56 | $22.00 | $22.00 | $122.22 | 3-Stars |
| Sole Elite Group (SOLE) | Dawson James Securities | 3.00 | $10.00 | $12.00 | $33.00 | n.a. |
| SynCardia Systems (TAHT) | Roth Capital Partners | 2.50 | $10.00 | $12.00 | $27.50 | n.a. |
| N/C = No Call Best effort offering | ||||||
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of Sept. 14, 2015 | Manager(s) | Offered | Raised | Price | 9/18/15 | Change |
| REGENXBIO Inc. (RGNX) | Morgan Stanley/ BofA Merrill Lynch/ Piper Jaffray | 6.30 | $138.60 | $22.00 | $30.70 | 39.55% |
| Penumbra (PEN) | J.P. Morgan/ BofA Merrill Lynch | 4.00 | $120.00 | $30.00 | $41.30 | 37.67% |
| Nabriva Therapeutics AG (NBRV) | Leerink Partners/ RBC Capital Markets | 9.00 | $92.25 | $10.25 | $13.34 | 30.15% |
